Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.

D'Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL.

Cancer Discov. 2018 Aug;8(8):944-957. doi: 10.1158/2159-8290.CD-17-1417. Epub 2018 Jun 11.

PMID:
29891538
2.

Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors.

Merryweather-Clarke AT, Tipping AJ, Lamikanra AA, Fa R, Abu-Jamous B, Tsang HP, Carpenter L, Robson KJ, Nandi AK, Roberts DJ.

BMC Genomics. 2016 Oct 21;17(1):817.

3.

A network including TGFβ/Smad4, Gata2, and p57 regulates proliferation of mouse hematopoietic progenitor cells.

Billing M, Rörby E, May G, Tipping AJ, Soneji S, Brown J, Salminen M, Karlsson G, Enver T, Karlsson S.

Exp Hematol. 2016 May;44(5):399-409.e5. doi: 10.1016/j.exphem.2016.02.001. Epub 2016 Feb 10.

PMID:
26876150
4.

Correction: distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment.

Lamikanra AA, Merryweather-Clarke AT, Tipping AJ, Roberts DJ.

PLoS One. 2015 Apr 22;10(4):e0127124. doi: 10.1371/journal.pone.0127124. eCollection 2015. No abstract available.

5.

Distinct mechanisms of inadequate erythropoiesis induced by tumor necrosis factor alpha or malarial pigment.

Lamikanra AA, Merryweather-Clarke AT, Tipping AJ, Roberts DJ.

PLoS One. 2015 Mar 17;10(3):e0119836. doi: 10.1371/journal.pone.0119836. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127124.

6.

Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors.

May G, Soneji S, Tipping AJ, Teles J, McGowan SJ, Wu M, Guo Y, Fugazza C, Brown J, Karlsson G, Pina C, Olariu V, Taylor S, Tenen DG, Peterson C, Enver T.

Cell Stem Cell. 2013 Dec 5;13(6):754-68. doi: 10.1016/j.stem.2013.09.003. Epub 2013 Oct 10.

7.

Single-cell gene expression analysis reveals genetic associations masked in whole-tissue experiments.

Wills QF, Livak KJ, Tipping AJ, Enver T, Goldson AJ, Sexton DW, Holmes C.

Nat Biotechnol. 2013 Aug;31(8):748-52. doi: 10.1038/nbt.2642. Epub 2013 Jul 21.

PMID:
23873083
8.

Methods for qPCR gene expression profiling applied to 1440 lymphoblastoid single cells.

Livak KJ, Wills QF, Tipping AJ, Datta K, Mittal R, Goldson AJ, Sexton DW, Holmes CC.

Methods. 2013 Jan;59(1):71-9. doi: 10.1016/j.ymeth.2012.10.004. Epub 2012 Oct 16.

9.

Inferring rules of lineage commitment in haematopoiesis.

Pina C, Fugazza C, Tipping AJ, Brown J, Soneji S, Teles J, Peterson C, Enver T.

Nat Cell Biol. 2012 Feb 19;14(3):287-94. doi: 10.1038/ncb2442.

PMID:
22344032
10.

GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia.

Rodrigues NP, Tipping AJ, Wang Z, Enver T.

Int J Biochem Cell Biol. 2012 Mar;44(3):457-60. doi: 10.1016/j.biocel.2011.12.004. Epub 2011 Dec 14. Review.

11.

High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle.

Tipping AJ, Pina C, Castor A, Hong D, Rodrigues NP, Lazzari L, May GE, Jacobsen SE, Enver T.

Blood. 2009 Mar 19;113(12):2661-72. doi: 10.1182/blood-2008-06-161117. Epub 2009 Jan 23.

12.

GATA-2 regulates granulocyte-macrophage progenitor cell function.

Rodrigues NP, Boyd AS, Fugazza C, May GE, Guo Y, Tipping AJ, Scadden DT, Vyas P, Enver T.

Blood. 2008 Dec 15;112(13):4862-73. doi: 10.1182/blood-2008-01-136564. Epub 2008 Oct 7.

13.

Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1.

Robert-Moreno A, Guiu J, Ruiz-Herguido C, López ME, Inglés-Esteve J, Riera L, Tipping A, Enver T, Dzierzak E, Gridley T, Espinosa L, Bigas A.

EMBO J. 2008 Jul 9;27(13):1886-95. doi: 10.1038/emboj.2008.113. Epub 2008 Jun 5.

14.

Novel compounds with antiproliferative activity against imatinib-resistant cell lines.

Lerma EI, Nguyen VA, Wang T, Tipping A, Melo JV, Kufe D, Austin DJ, Deisseroth A.

Mol Cancer Ther. 2007 Feb;6(2):655-66. Epub 2007 Jan 31.

15.

ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis.

Schuh AH, Tipping AJ, Clark AJ, Hamlett I, Guyot B, Iborra FJ, Rodriguez P, Strouboulis J, Enver T, Vyas P, Porcher C.

Mol Cell Biol. 2005 Dec;25(23):10235-50.

16.

Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C.

Sánchez-Arévalo Lobo VJ, Aceves Luquero CI, Alvarez-Vallina L, Tipping AJ, Viniegra JG, Hernández Losa J, Parada Cobo C, Galán Moya EM, Gayoso Cruz J, Melo JV, Ramón y Cajal S, Sánchez-Prieto R.

Biochem J. 2005 Apr 1;387(Pt 1):231-8.

17.

Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate.

Tipping AJ, Baluch S, Barnes DJ, Veach DR, Clarkson BM, Bornmann WG, Mahon FX, Goldman JM, Melo JV.

Leukemia. 2004 Aug;18(8):1352-6.

PMID:
15201856
18.

Comparative gene expression profile of p185(Bcr-Abl) versus p210(Bcr-Abl) expressing cells.

Tipping AJ, Melo JV.

Leuk Res. 2004 Mar;28(3):219-20. No abstract available.

PMID:
14687613
19.

Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate.

Tipping AJ, Deininger MW, Goldman JM, Melo JV.

Exp Hematol. 2003 Nov;31(11):1073-80.

PMID:
14585372
20.

Molecular diagnosis of Fanconi anemia and dyskeratosis congenita.

Tipping AJ, Vulliamy TJ, Morgan NV, Dokal I.

Methods Mol Med. 2004;91:3-17. No abstract available.

PMID:
14573926
21.

Imatinib mesylate in combination with other chemotherapeutic drugs: in vitro studies.

Tipping AJ, Melo JV.

Semin Hematol. 2003 Apr;40(2 Suppl 2):83-91. Review.

PMID:
12783381
22.

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs.

Tipping AJ, Mahon FX, Zafirides G, Lagarde V, Goldman JM, Melo JV.

Leukemia. 2002 Dec;16(12):2349-57.

23.

Analysis of the distribution of copper amine oxidase in cell walls of legume seedlings.

Laurenzi M, Tipping AJ, Marcus SE, Knox JP, Federico R, Angelini R, McPherson MJ.

Planta. 2001 Nov;214(1):37-45.

PMID:
11762169
24.

Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells.

Tipping AJ, Mahon FX, Lagarde V, Goldman JM, Melo JV.

Blood. 2001 Dec 15;98(13):3864-7.

25.
26.

Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.

Tipping AJ, Pearson T, Morgan NV, Gibson RA, Kuyt LP, Havenga C, Gluckman E, Joenje H, de Ravel T, Jansen S, Mathew CG.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5734-9.

27.

Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9.

Demuth I, Wlodarski M, Tipping AJ, Morgan NV, de Winter JP, Thiel M, Gräsl S, Schindler D, D'Andrea AD, Altay C, Kayserili H, Zatterale A, Kunze J, Ebell W, Mathew CG, Joenje H, Sperling K, Digweed M.

Eur J Hum Genet. 2000 Nov;8(11):861-8.

28.

High frequency of large intragenic deletions in the Fanconi anemia group A gene.

Morgan NV, Tipping AJ, Joenje H, Mathew CG.

Am J Hum Genet. 1999 Nov;65(5):1330-41.

29.

A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.

Kupfer G, Naf D, Garcia-Higuera I, Wasik J, Cheng A, Yamashita T, Tipping A, Morgan N, Mathew CG, D'Andrea AD.

Exp Hematol. 1999 Apr;27(4):587-93.

PMID:
10210316
30.

Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene.

Wijker M, Morgan NV, Herterich S, van Berkel CG, Tipping AJ, Gross HJ, Gille JJ, Pals G, Savino M, Altay C, Mohan S, Dokal I, Cavenagh J, Marsh J, van Weel M, Ortega JJ, Schuler D, Samochatova E, Karwacki M, Bekassy AN, Abecasis M, Ebell W, Kwee ML, de Ravel T, CG Mathew, et al.

Eur J Hum Genet. 1999 Jan;7(1):52-9.

31.

The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.

Crawford J, Ianzano L, Savino M, Whitmore S, Cleton-Jansen AM, Settasatian C, d'apolito M, Seshadri R, Pronk JC, Auerbach AD, Verlander PC, Mathew CG, Tipping AJ, Doggett NA, Zelante L, Callen DF, Savoia A.

Genomics. 1999 Feb 15;56(1):90-7.

PMID:
10036189
32.

Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer.

Whitmore SA, Settasatian C, Crawford J, Lower KM, McCallum B, Seshadri R, Cornelisse CJ, Moerland EW, Cleton-Jansen AM, Tipping AJ, Mathew CG, Savnio M, Savoia A, Verlander P, Auerbach AD, Van Berkel C, Pronk JC, Doggett NA, Callen DF.

Genomics. 1998 Sep 15;52(3):325-31.

PMID:
9790751
33.

The genomic organization of the Fanconi anemia group A (FAA) gene.

Ianzano L, D'Apolito M, Centra M, Savino M, Levran O, Auerbach AD, Cleton-Jansen AM, Doggett NA, Pronk JC, Tipping AJ, Gibson RA, Mathew CG, Whitmore SA, Apostolou S, Callen DF, Zelante L, Savoia A.

Genomics. 1997 May 1;41(3):309-14.

PMID:
9169126
34.

Cloning and molecular analysis of the pea seedling copper amine oxidase.

Tipping AJ, McPherson MJ.

J Biol Chem. 1995 Jul 14;270(28):16939-46.

35.

Cloning and sequence analysis of a pea seedling amine oxidase gene.

Tipping AJ, McPherson MJ.

Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):317S. No abstract available.

PMID:
8224462
36.

Spiritual care for the dying.

Tipping A.

Can Pharm J. 1981 Jul;114(7):258-9. No abstract available.

PMID:
10252131

Supplemental Content

Loading ...
Support Center